ANESTHESIOLOGY® 2023
Moscone Center South Building
Hall D, Room 11
A non-CME satellite symposium presented by an ASA Industry Supporter.
Get into a golden state of mind with new evidence to improve medication safety, costs, and patient outcomes. Medication errors associated with the administration of the wrong dose and/or wrong concentration are believed to be more prevalent when frontline practitioners are provided with a parenteral product that requires additional manipulation (partial doses, reconstitution, or dilution) at the bedside.
Many organizations, including ISMP, ASHP, and APSF have recommended to avoid the unnecessary, error-prone complexity of IV push medication preparation and administration, calling for all stakeholders to re-evaluate current products administered and standardize as much as possible to ready-to-administer (RTA) formulations and concentrations.
Using examples of events that have been reported to the ISMP National Medication Errors Reporting Program (ISMP MERP) and data from cost-effectiveness research studies, faculty will describe the key vulnerabilities when IV medications require manipulation at the bedside that have led to errors and patient harm. The speakers will review data from studies that compare the cost and safety of manufacturer-prepared prefilled ready-to-administer (RTA) products compared to traditional vial-and-syringe products. Additionally, new evidence-based research data showing the relationship between improved patient outcomes and specific opioid product availability will be discussed.
Intended Audience:
- Anesthesiologists
- Certified Registered Nurse Anesthesiologists
- Medical Residents and Fellows
- Nurses and Pharmacists
- Professionals responsible for Risk, Quality, and Safety in the perioperative setting
- Administrative Leaders and Directors of Perioperative Areas
Learning Objectives:
Following completion of this activity, participants will be able to:
- Describe the risks associated with preparation and administration of IV medications that are manipulated in perioperative and procedural care settings.
- Compare studies evaluating the cost and safety of manufacturer-prepared ready-to-administer (RTA) products versus traditional vial-and-syringe products.
- Recognize new evidence demonstrating improved patient outcomes when providers are presented with RTA products.
Introduction and Overview:
Rita K. Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP
Speaker(s):
Risks Associated with the Preparation and Administration of IV Medications
Rita K. Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP
Comparing Costs and Safety Implications of Ready-to-Administer (RTA) Products and Traditional Vial-and-Syringe Products
John B. Hertig, PharmD, MS, CPPS, FASHP, Vice-Chair and an Associate Professor of Pharmacy Practice in the Butler University College of Pharmacy and Health Sciences
The Effect of Opioid Vial Sizes on Patient Outcomes
Satya Krishna Ramachandran, MD, Associate Professor, Harvard Medical School, Anesthesiologist, Beth Israel Deaconess Medical Center
This activity is supported by Fresenius Kabi.
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis. Lunch will be provided. Doors open at 11:15am.
CE Accreditation
No continuing education credits are available for this activity.
A non-CME satellite symposium presented by an ASA Industry Supporter.
